Shahinaz Mohamed | Clinical Research | Best Researcher Award

Dr. Shahinaz Mohamed | Clinical Research | Best Researcher Award

Clinical Research Assistant at King Abdullah International Medical Research Center, Saudi Arabia

Dr. Shahinaz F. Mohamed is a highly experienced Medical Writer and Clinical Research Professional with over 12 years of expertise in the medical research field. She holds a Master of Public Health (MPH) from the University of Essex, UK, and is a Certified Clinical Research Associate (CCRA®). With a strong background in clinical trials, medical writing, and regulatory compliance, she has played a pivotal role in developing and managing clinical study protocols, ethical review processes, and scientific publications. Currently, she serves as a Senior Clinical Research Epidemiologist & Medical Writer at King Abdullah International Medical Research Center (KAIMRC), Saudi Arabia. Dr. Mohamed has significantly contributed to peer-reviewed medical journals, showcasing her expertise in public health, evidence-based medicine, and digital health research. Her work in Good Clinical Practice (GCP) training, clinical trial documentation, and regulatory compliance has established her as a key figure in the field of clinical and translational research.

professional profiles📖

ORCID

Google scholar

Education 🎓

Dr. Shahinaz Mohamed has a diverse and well-rounded educational background in public health, clinical research, and medical sciences. She earned her Master of Public Health (MPH) from the University of Essex, UK, in 2019, which provided her with a strong foundation in epidemiology, healthcare policy, and biostatistics. She further enhanced her qualifications by obtaining the Certified Clinical Research Associate (CCRA®) from the USA in 2022, demonstrating her expertise in clinical trials and regulatory compliance. Additionally, she holds a Certified Clinical Research Coordinator (CCRC®) certification from KSA (2013), further establishing her credibility in research methodology and ethical compliance. Her academic journey began with a Diploma of Higher Education in Histopathology from Egypt (2006) and a Bachelor of Veterinary Medicine from Egypt (2004), providing her with deep knowledge in biomedical sciences and medical research. Her comprehensive education has equipped her with the skills necessary for high-quality clinical research and medical writing.

work Experience💼

Dr. Shahinaz Mohamed has been an integral part of the clinical research field for over a decade, primarily serving as a Senior Clinical Research Epidemiologist & Medical Writer at King Abdullah International Medical Research Center (KAIMRC), Saudi Arabia, since 2011. In this role, she has been responsible for developing clinical study protocols, drafting case report forms, and preparing informed consent documents. She has also played a key role in the scientific and ethical evaluation of research proposals for Institutional Review Board (IRB) approval, ensuring compliance with Good Clinical Practice (GCP) and international regulatory standards. Her work includes conducting literature reviews, statistical analysis, and data interpretation for scientific publications, as well as peer-reviewed journal articles and systematic reviews. In addition, she has contributed as a Research Proposal Reviewer and IRB Member, evaluating preclinical and clinical studies and advising investigators on study design, ethical considerations, and publication guidelines.

Research Focus

Dr. Shahinaz Mohamed’s research primarily focuses on infectious diseases, clinical trials, endocrinology, and public health. Her work in infectious disease epidemiology has contributed to the treatment and management of conditions such as Middle East respiratory syndrome (MERS-CoV) and diabetes. She has played a vital role in clinical trials and evidence-based medicine, ensuring the development of robust interventional studies to improve patient outcomes. In the field of endocrinology and metabolic disorders, she has examined the impact of insulin therapy and lipid metabolism in diabetes patients. Additionally, her research extends to medical ethics and GCP compliance, ensuring that clinical trials adhere to the highest ethical standards. She has also been actively involved in digital health and healthcare data analysis, exploring the adoption of personal health records and AI-driven medical research solutions. Her multidisciplinary research contributes to medical advancements and improved healthcare policies.

Awards & Honors🏆 

Dr. Shahinaz Mohamed has been recognized for her significant contributions to clinical research and medical writing through various awards and honors. She earned the prestigious Certified Clinical Research Associate (CCRA®) certification from the USA in 2022, affirming her expertise in clinical trials and research ethics. Additionally, she has been an ICH-GCP Instructor and Certification Trainer, providing Good Clinical Practice (GCP) training for medical professionals. She has been invited as a presenter at Research Methodology & Biostatistics Workshops (Nature Research Academies, 2022) and has served as a Clinical Research Capability Trainer for AstraZeneca in 2022. Her participation as a speaker at Annual Clinical Research Symposiums (KAIMRC, Almoosa Specialist Hospital) further highlights her influence in the medical research community. Recognized for her expertise in Regulatory & Quality Management in Clinical Research (SFDA, FDA compliance), she continues to be a key figure in clinical research training and regulatory affairs.

Skills 🛠️ 

Dr. Shahinaz Mohamed possesses a diverse skill set that allows her to excel in clinical research, scientific writing, and regulatory compliance. She is highly proficient in medical and scientific writing, specializing in manuscripts, abstracts, and study protocols. Her expertise in clinical research methodology and statistical analysis (SPSS, STATA, R) enables her to conduct comprehensive data analysis and interpretation. She is skilled in Institutional Review Board (IRB) submissions and compliance, ensuring ethical approval of clinical trials. Additionally, she is a Good Clinical Practice (GCP) instructor, providing training in research ethics and regulatory compliance. Her proficiency in systematic reviews, manuscript editing, and peer-review coordination makes her a highly sought-after expert in medical publishing. She is also well-versed in digital health research and AI-driven healthcare solutions, contributing to the advancement of innovative medical technologies. With fluency in English and Arabic, she effectively communicates research findings and regulatory guidelines across diverse medical communities.

Conclusion✅

Shahinaz F. Mohamed possesses outstanding qualifications for the Best Researcher Award, given her strong research background, publication record, expertise in clinical research, and commitment to research ethics and training. Her contributions in medical writing, research methodology, and regulatory compliance make her a highly competitive candidate. To further strengthen her profile, she may consider leading independent research projects, contributing to groundbreaking studies, and securing research grants. Nevertheless, her current accomplishments make her a strong contender for this prestigious award. 🚀🏆

📚Publications to Noted

Treatment of Middle East respiratory syndrome with a combination of lopinavir-ritonavir and interferon-β1b (MIRACLE trial): study protocol for a randomized controlled trial

Authors: YM Arabi, A Alothman, HH Balkhy, A Al-Dawood, S AlJohani, S Al Harbi, …

Citations: 370

Year: 2018

Molecular Analysis of Congenital Hypothyroidism in Saudi Arabia: SLC26A7 Mutation Is a Novel Defect in Thyroid Dyshormonogenesis

Authors: M Zou, AS Alzahrani, A Al-Odaib, MA Alqahtani, O Babiker, RA Al-Rijjal, …

Citations: 72

Year: 2018

Comparison of Insulin Pump Therapy and Multiple Daily Injections Insulin Regimen in Patients with Type 1 Diabetes During Ramadan Fasting

Authors: MD Reem Alamoudi, MD, MHSc, Maram Alsubaiee, MD, Ali Alqarni, MD, Yousef …

Citations: 39

Year: 2017

Statistical analysis plan for the Pneumatic CompREssion for PreVENting Venous Thromboembolism (PREVENT) trial: a study protocol for a randomized controlled trial

Authors: Y Arabi, F Al-Hameed, KEA Burns, S Mehta, S Alsolamy, M Almaani, …

Citations: 14

Year: 2018

The Dialysis Outcomes and Practice Patterns Study Phase 5 in the Gulf Cooperation Council Countries Design and Study Methods

Authors: Pisoni, Ronald L., BA Bieber, J Al Wakeel, S Al Arrayed, N Alkandari, …

Citations: 11

Year: 2016

Surveillance or no surveillance for deep venous thrombosis and outcomes of critically ill patients: a study protocol and statistical analysis plan

Authors: YM Arabi, KEA Burns, F Al-Hameed, S Alsolamy, M Almaani, …

Citations: 7

Year: 2018

Replacing protein via enteral nutrition in a stepwise approach in critically ill patients: the REPLENISH randomized clinical trial protocol

Authors: YM Arabi, HM Al-Dorzi, M Sadat, D Muharib, H Algethamy, F Al-Hameed, …

Citations: 6

Year: 2023

The effect of intermittent pneumatic compression on deep-vein thrombosis and ventilation-free days in critically ill patients with heart failure

Authors: HM Al-Dorzi, A Al-Dawood, FM Al-Hameed, KEA Burns, S Mehta, J Jose, …

Citations: 5

Year: 2022

Statistical analysis plan for the replacing protein via enteral nutrition in a stepwise approach in critically ill patients (REPLENISH) randomized clinical trial

Authors: YM Arabi, HM Al-Dorzi, O Aldibaasi, M Sadat, J Jose, D Muharib, …

Citations: 3

Year: 2024

Association of advanced lipoprotein subpopulation profiles with insulin resistance and inflammation in patients with type 2 diabetes Mellitus

Authors: A Bakillah, KK Obeid, M Al Subaiee, AF Soliman, M Al Arab, SF Bashir, …

Citations: 3

Year: 2023

 

Manença Cristiano Nhanga| Materiais| Excellence in Research Award

Mr.Manença Cristiano Nhanga |Materiais| Excellencein Research Award

Researcher staff at Púnguè University,Mozambique.
Manença Cristiano Nhanga is a researcher and staff member at Púnguè University, Mozambique. His academic and research interests focus on areas related to engineering, environmental sciences, and sustainable development. With a strong commitment to advancing knowledge and innovation, he actively contributes to research projects and academic initiatives at the university.
professional profiles📖

Orcid

Education 🎓

Púnguè University, Mozambique (2020 – 2024)Degree: Bachelor’s in Physics Teaching with a focus on Renewable Energy.Distinction: Best student in the Faculty of Exact and Technological Sciences with an average of 15/20.University of Minho, Portugal (Feb – June 2024)Conducted a research project on “Evaluation of Heavy Metals Content in Plastic Bags Used as Part of Food Cooking Containers by the Mozambican Community” under the guidance of Prof. Dr. Maria Dulce Geraldo, Prof. Dr. Manuel Filipe Costa, and Prof. Dr. Sérgio Nhapulo.Global Inclusive Society, Brazil (2023)Certified in International Relations, Cooperativism, Geopolitics, and Public Speaking.Mopeia Secondary School, Zambezia (2014-2018)Achieved the best academic performance and was exempted from the national examination in 10th grade.

work Experience💼

University of Minho, Portugal (Feb – June 2024)Poster Presentation at VII ETCAQ: Evaluation of Zn in Plastic Bags used as Food Containers in Mozambique.Book Chapter Author: Science Education and Sustainability in Hands-On Science 2024.Article Author: Evaluation of Heavy Metals in Plastic Bags used as Improvised Food Cooking Covers: A Case Study from Mozambique (Sustainability Journal 2025, 17, 964).Conference Participation:VII Meeting of Chemical Characterization and Analysis Techniques (June 7, 2024)Catalysis in Industry Lecture by Prof. Pham Thanh Huyen from Hanoi University of Science and Technology (June 20, 2024)Science Fair Jury Member at Colégio do Minho (May 23, 2024)Oral Presentation at the 21st Annual International Hands-On Science Conference 2024 in Goiás, Brazil.Electro Expresso, Lda [Assistant]Worked in service, maintenance, and logistics.Global Inclusive Society [Assistant Teacher] (2023)Taught English at intermediate and pre-advanced levels.EISA-JOINT Mozambique [Election Representative, Luabo] (2019)

Research Focus

Nhanga’s research primarily explores:Environmental Sustainability and Heavy Metal ContaminationRenewable Energy Applications in Physics EducationScience Education and Sustainable DevelopmentMaterial Safety in Food PackagingHis work addresses societal challenges in Mozambique, particularly regarding food safety, environmental impact, and education in underdeveloped regions.

Awards & Honors🏆 

Best Student in Physics Course – Púnguè University (2024)
🏆 Best Academic Performance – University of Minho (ERASMUS+ ICM, 2024)
🏆 Best Academic Performance in Secondary School – Mopeia Secondary School (2018)

Conclusion✅

Based on his academic excellence, research achievements, and international collaboration, Manença Cristiano Nhanga is a highly suitable candidate for the Excellence in Research Award. By enhancing his publication record, research funding, and interdisciplinary studies, he can further establish himself as a leading scholar in environmental and material sciences.

📚Publications to Noted

  • Nhanga, M. C., Geraldo, D., Nhapulo, S. L., João, A. F., Carneiro, J., & Costa, M. F. M. (2025). Evaluation of Heavy Metal Content in Plastic Bags Used as Improvised Food Cooking Covers: A Case Study from the Mozambican Community. Sustainability, 17, 964.

  • Nhanga, M. C. (2024). Evaluation of Heavy Metal Content in Plastic Bags Used as Part of Food Cooking Containers: A Socio-educational Sustainability Perspective in Mozambique. In Science Education and Sustainability (pp. XX-XX). ISBN 978-84-8158-971-9.

 

Ajoy Kumar Bauri | Isolation | Best Researcher Award

Dr. Ajoy kumar Bauri | Isolation | Best Researcher Award

Scientific Officer at Bhabha Atomic Research Centre, Trombay, Mumbai , India

Dr. Ajoy Kumar Bauri is a Senior Scientist (SO ‘F’) at the Bio-Organic Division, Bhabha Atomic Research Centre (BARC), Mumbai, Dr. Bauri’s primary research interests lie in the investigation of bioactive secondary metabolites from medicinal plants, marine organisms, and microorganisms. He is a specialist in isolating and characterizing natural products that serve as potential pharmaceutical agents. His work focuses on developing safer, more potent drugs from natural resources such as medicinal herbs and marine organisms, contributing significantly to the fields of pharmacology and biotechnology. Through his groundbreaking research, Dr. Bauri is advancing the development of novel agents with anti-cancer, anti-inflammatory, and anti-microbial properties, aiming to improve global healthcare.

professional profiles📖

Education 🎓

Dr. Ajoy Kumar Bauri holds a Ph.D. in Science, specializing in the isolation and characterization of bioactive natural products, particularly secondary metabolites from medicinal plants and marine organisms. His educational background laid a strong foundation for his scientific career, enabling him to develop a deep understanding of bio-organic chemistry and pharmacology. His focus on medicinal plants, natural product chemistry, and molecular pharmacology stems from his academic pursuits, during which he gained expertise in advanced chromatographic techniques, spectroscopy, and the structural elucidation of bioactive compounds. He continuously strives to stay updated with the latest advancements in his field, ensuring his work remains at the cutting edge of bio-organic and pharmaceutical research.

work Experience💼

Dr. Ajoy Kumar Bauri has over three decades of research experience at Bhabha Atomic Research Centre (BARC), Mumbai. During his tenure, he has specialized in investigating bioactive secondary metabolites from traditional medicinal plants, marine organisms, and microorganisms. Dr. Bauri has extensive experience in utilizing advanced chromatographic techniques, including column chromatography, high-performance liquid chromatography, and thin-layer chromatography to isolate bioactive compounds. His expertise also extends to spectroscopic analysis, employing various techniques such as NMR, mass spectrometry, IR spectroscopy, and X-ray diffraction to elucidate the structures of isolated compounds. In addition to his laboratory work, Dr. Bauri has studied the potential biomedical applications of these compounds, including their anti-cancer, anti-ulcer, anti-inflammatory, and anti-microbial activities. He has also explored the biosynthetic and biotransformation processes of these compounds, using bacterial and fungal cultures to produce novel analogues for further study.

Awards and Honors

Dr. Ajoy Kumar Bauri’s contributions to the field of bioactive natural products have earned him recognition in various scientific circles. Although specific awards and honors are not detailed in the provided information, his work is widely acknowledged in the scientific community for its potential impact on pharmaceutical research. His focus on isolating bioactive compounds from natural sources and contributing to drug development, especially in the areas of anti-cancer, anti-inflammatory, and anti-microbial therapies, has made him a valuable member of the Bhabha Atomic Research Centre (BARC). He has also been instrumental in the exploration of marine organisms and microorganisms as sources of novel bioactive molecules. Dr. Bauri’s research continues to influence future drug development, and his scientific excellence makes him a candidate for recognition in national and international research awards in pharmaceutical science and bio-organic chemistry.

Research Focus

Dr. Ajoy Kumar Bauri’s primary research focus is on the investigation of bioactive secondary metabolites derived from medicinal plants, marine organisms, and microorganisms. He isolates and characterizes new pharmaceutical agents, especially those used in traditional herbal and Ayurvedic systems. Dr. Bauri’s work emphasizes the exploration of natural products as a safer and more potent alternative to synthetic drugs, focusing on their potential in treating diseases like cancer, infections, ulcers, and inflammation. His research spans the isolation of compounds using advanced chromatographic techniques, followed by detailed structural characterization through various spectroscopic methods such as NMR, mass spectrometry, and X-ray diffraction. Additionally, Dr. Bauri investigates the biosynthesis and biotransformation of these compounds to create novel analogues, contributing to the development of new, more effective therapeutics. His research is aimed at the biomedical applications of these compounds, with an emphasis on their pharmacological activities and overall therapeutic potential.

Skills

Dr. Ajoy Kumar Bauri possesses an extensive skill set that enables him to carry out advanced research in the field of bioactive natural products. His technical skills include proficiency in chromatographic techniques such as column chromatography, high-performance liquid chromatography (HPLC), and thin-layer chromatography (TLC), which he uses to isolate bioactive compounds. He is highly skilled in spectroscopic methods such as one-dimensional and two-dimensional NMR, mass spectrometry, infrared spectroscopy, and single-crystal X-ray diffraction, allowing him to accurately characterize the structure of isolated compounds. Additionally, Dr. Bauri has expertise in testing the pharmacological properties of natural products, including anti-cancer, anti-ulcer, anti-inflammatory, and anti-microbial activities. His ability to explore biosynthesis and biotransformation pathways using microbial cultures adds depth to his research, contributing to the creation of novel drug analogues. His comprehensive approach to natural product chemistry, coupled with his biomedical focus, ensures the applicability of his research in pharmaceutical development.

Conclusion✅

Dr. Ajoy Kumar Bauri’s exceptional contributions to the field of bioactive natural products, his innovative research methodologies, and his focus on the biomedical applications of his findings position him as a strong candidate for the Best Researcher Award. His work addresses crucial health challenges, particularly in oncology, infectious diseases, and inflammation, through the development of pharmaceutical agents derived from nature. By expanding his outreach and fostering collaborations, Dr. Bauri could further amplify the global impact of his research.

📚Publications to Noted

Exhibition of Förster resonance energy transfer from CdSe/ZnS quantum dot to zinc porphyrazine studied in solution.
J. Mol. Liq., 276, 770-778 (2019)
Year: 2019
Author: Ajoy Bauri

Analysis of Chemical constituents of Steam Distillate of Trachyspermum roxburghianum
Am. J. Food Sci. & Nutrition, 5(4), 76-81 (2018)
Year: 2018
Author: Ajoy Bauri

Anti-proliferative Active Flavones from the Methanol Extract of Indian Herb Artemisia reticulata.
Am. J. Pharma & Pharmacol. 5(4), 27-32 (2018)
Year: 2018
Author: Ajoy Bauri

Anti-proliferative Allyl phenol from the Methanol Extract of Piper betle.
Am. J. Pharma & Pharmacol. 5(3), 13-18 (2018)
Year: 2018
Author: Ajoy Bauri

Molecular assembly of PC70BM with a designed monoporhyrin: Spectroscopic investigation in solution and theoretical calculations.
J. Mol. Liq., 272, 137-150 (2018)
Year: 2018
Author: Ajoy Bauri

Study of Chemical Physics on Energy Transfer Phenomenon between Quantum Dots and Designed Diporphyrin in Solution.
J. Mol. Liq., 263, 64-71 (2018)
Year: 2018
Author: Ajoy Bauri

Synthesis and Evaluation of Polyphenolic Malabaricones for their Anti-cancer Potential.
BARC NEWSLETTER Research Article, September-October 2018
Year: 2018
Author: Ajoy Bauri

The spice-derived phenolic, malabaricone B induces mitochondrial damage in A549 cells via p53-independent pathway.
Food & Function, 14:9(11), 5715-5727 (2018)
Year: 2018
Author: Ajoy Bauri

Crystal structure of tetrahydro seselin, an angular pyranocoumarin.
Acta Cryst. E, 2017-06-21
Year: 2017
DOI: 10.1107/S205698901700932X
Author: Ajoy Bauri

(10R,13R)-17-(6-Hydroxy-5-methylheptan-2-yl)10,13-dimethyl-2,3,4,7,10,11,12,13,14,15,16,17,-tetradecahydro-1H cyclopenta[a] phenanthre-3-ol hemihydrate: a bioactive steroid isolated from the Indian herb Artemisia reticulata.
Year: 2017
Author: Ajoy Bauri

Crystal structure of a photobiologically active brominated angular pyranocoumarin: bromo hydroxyl seselin.
Acta Cryst (2017). E73, 453-455
Year: 2017
Author: Ajoy Bauri

Crystal structure of dibromomethoxy seselin, a photobiologically active pyranocoumarin.
Acta Cryst (2017). E73, 774-776
Year: 2017
Author: Ajoy Bauri

Crystal structure of tetrahydro seselin, an angular pyranocoumarin.
Acta Cryst (2017). E73, 1117-1120
Year: 2017
Author: Ajoy Bauri

Identification of GTP binding nuclear protein Ran as an upregulation target in acetoin glycoside mediated plant growth enhancement.
Natural Product Journals, 7, 1-7 (2017)
Year: 2017
Author: Ajoy Bauri

Crystal structure of Bergapten, a photomutagenic and photobiologically active furanocoumarin.
Acta Cryst. E, 2016-07
Year: 2016
Author: Ajoy Bauri

Crystal structure of bergapten: a photomutagenic and photobiologically active furanocoumarin.
Cryst. Acta. E72, 1194-1196 (2016)
Year: 2016
Author: Ajoy Bauri

 

Mehran Arabi | Animal Physiology | Best Researcher Award

Yohandys Alexis Zulueta Leyva | Biophysics | Best Researcher Award